不同剂量阿托伐他汀对急性脑梗死患者颈动脉粥样硬化斑块的治疗效果

邵卫东

（陕西省商洛市第二人民医院内三科，陕西商洛，726000）

浏览次数：142次 下载次数：344次

摘要：

目的 探讨不同剂量阿托伐他汀对急性脑梗死患者动脉粥样硬化斑块的影响。方法 选取2014年1月至2015年1月于我院进行治疗的合并颈动脉粥样硬化斑块的急性脑梗死患者122例作为研究对象，根据随机数字表法将其随机分为A组(41例)、B组(41例)及C 组(40例)。A组患者给予常规治疗，B组患者在常规治疗上加用小剂量阿托伐他汀，C组患者在常规治疗基础上加用大剂量阿托伐他汀。比较三组患者治疗前后血脂水平、颈动脉粥样硬化斑块面积及不良反应发生情况。结果 B、C两组患者治疗后TC、TG及LDL均较治疗前明显下降，HDL较治疗前明显升高，且均较A组有显著差异(P<0.05)。治疗前三组患者斑块面积无显著差异，治疗后C组斑块面积明显下降(P<0.05)，A、B两组与治疗前比较差异不显著(P>0.05)。三组患者均无严重不良反应发生。结论 阿托伐他汀可显著改善急性脑梗死患者颈动脉粥样硬化，以大剂量阿托伐他汀疗效更佳。

关键词：急性脑梗死；颈动脉粥样硬化；阿托伐他汀

中图分类号：R743.3文献标志码：A文章编号：2096-1413(2017)01-0027-02

Influence of different dose of atovastatin on carotid atherosclerotic plaques of patients with acute cerebral infarction
SHAO Wei-dong
(the 3rd Internal Medicine Department, Shangluo No.2 People s Hospital of Shaanxi Province, Shangluo 726000, China)

ABSTRACT: Objective To explore the influence of different dose of atovastatin on carotid atherosclerotic plaques of patients with acute cerebral infarction. Methods From January 2014 to January 2015, 122 patients with acute cerebral infarction and carotid atherosclerotic plaques accepted in our hospital were selected and randomly divided into group A (41 cases), group B (41 cases) and group C (40 cases). Group A was given normal treatment, group B received small dose of atovastatin, group C was given large dose of atovastatin. The lipid levels, area of carotid atherosclerotic plaques and adverse reactions of the three groups were compared. Results The TC, TG and LDL expression level of group B and C after treatment decreased and HDL expression level increased compared with before treatment and group A with statistically significant difference (P<0.05). The area of carotid atherosclerotic plaques before treatment of the three groups had no statistically difference significance. The area of carotid atherosclerotic plaques of group C after treatment was obviously decreased (P<0.05), while group A and B had no statistically significant difference (P>0.05). There was no serious adverse reactions of the three groups. Conclusion Atovastatin can improve the carotid atherosclerotic plaques of patients with acute cerebral infarction. Large dose of atovastatin can work better.
KEYWORDS: acute cerebral infarction; carotid atherosclerotic plaques; atovastatin

 

参考文献：

[1] SHEN B,LIU Q,GU Y,et al.Efficacy and safety evaluation on arterialthrom bolysis in treating acute cerebral Infarction[J].Cell Biochem Bio-phys,2015,73(2):297-304.

[2] 徐庶,吴秋义,郭刚,等.阿托伐他汀对动脉粥样硬化性脑梗死患者的调脂效果及颈动脉粥样硬化斑块的影响[J].中国现代神经疾病杂志,2015,15(11):904-908.

[3] 张云书.三种降脂药物对老年急性脑梗死合并高血脂患者治疗效果及血脂水平的影响分析[J].中国循证心血管医学杂志,2016,8(2):213-216.

[4] 安希文.中西医结合治疗脑梗死的疗效观察[J].中西医结合心血管病电子杂志,2015,3(21):36-37.

[5] 张小雪,张京芬,李锐铭,等.急性缺血性脑卒中低溶栓率的原因分析[J].中华医学杂志,2016,96(11):863-867.

[6] 韩容,赵志刚.尤瑞克林治疗急性脑梗死的疗效及安全性研究进展[J].药品评价,2016,13(2):29-33.

[7] 张伟萍.血清胰岛素样生长因子-1、低密度脂蛋白胆固醇与急性脑梗死患者颈动脉粥样硬化斑块稳定性的关系[J].浙江实用医学,2016,21(1):19-21.

[8] 刘凤辉,郝海燕,吴永辉,等.不同剂量阿托伐他汀对急性脑梗死病人脑血流储备能力的影响[J].中西医结合心脑血管病杂志,2016,14(1):78-80.

[9] 刘德祥,王晶.普罗布考、阿托伐他汀联合治疗颈动脉粥样硬化斑块临床疗效观察[J].内科,2016,11(1):13-15.

[10] 姬亚杰,任向阳.阿托伐他汀钙强化治疗急性脑梗死疗效及安全性评价[J].医药前沿,2016,6(1):62-63.

[11] 杨保华,叶晓林.不同剂量阿托伐他汀联合阿司匹林对急性脑梗死患者脑血流指标以及颈动脉粥样斑块的影响[J].医学综述,2016,22(6):1201-1204.